ISK

Results of Fundraising

Retrieved on: 
Tuesday, February 13, 2024

Such restrictions shall not apply to any Fundraising Shares acquired outside of Canada.

Key Points: 
  • Such restrictions shall not apply to any Fundraising Shares acquired outside of Canada.
  • This Announcement does not constitute a recommendation concerning any investor's options with respect to the UK Placing or any part of the Fundraising.
  • The Fundraising Shares to be issued pursuant to the Fundraising will not be admitted to trading on any stock exchange other than AIM, the TSX-V and Nasdaq Iceland’s main market.
  • The actual results, performance or achievements of the Company or developments in the industry in which the Company operates may differ materially from the future results, performance or achievements or industry developments expressed or implied by the forward-looking statements contained in this Announcement.

JBT Corporation Submits Enhanced Proposal to Acquire Marel hf

Retrieved on: 
Wednesday, December 13, 2023

JBT Corporation (NYSE: JBT), (“JBT” or the “Company”) a leading global technology solutions provider to high-value segments of the food & beverage industry, today confirmed that it has submitted a revised and significantly improved proposal to the Board of Directors of Marel hf.

Key Points: 
  • JBT Corporation (NYSE: JBT), (“JBT” or the “Company”) a leading global technology solutions provider to high-value segments of the food & beverage industry, today confirmed that it has submitted a revised and significantly improved proposal to the Board of Directors of Marel hf.
  • (“Marel”) to acquire all of the outstanding common stock of Marel for €3.40 per Marel share (ISK511 per share based on an ISK / EUR exchange rate of 150.3).
  • “JBT has long admired Marel, and there is significant strategic, cultural, and operational alignment between the companies.
  • JBT Corporation (NYSE: JBT) is a leading global technology solutions provider to high-value segments of the food & beverage industry.

Alvotech Completes $100 Million Convertible Bond Private Placement

Retrieved on: 
Monday, July 31, 2023

the largest shareholder of Alvotech, previously entered into an agreement with Alvotech under which ATP Holdings ehf.

Key Points: 
  • the largest shareholder of Alvotech, previously entered into an agreement with Alvotech under which ATP Holdings ehf.
  • committed to acquiring any of the Bonds which were not sold to other investors in the private placement.
  • Settlement of the private placement is expected to take place on August 11, 2023.
  • Alvotech will issue the Bonds, with a maturity date on December 20, 2025, pursuant to a convertible bond instrument dated December 20, 2022.

Correction to Total Amount in Announcement About Private Placement Published 2022-12-16 09:00 GMT to headline field

Retrieved on: 
Friday, December 16, 2022

REYKJAVIK, Iceland, Dec. 16, 2022 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced completion of a private placement of approximately US$70 million, at current exchange rates, of subordinated convertible bonds (the “Bonds”), which consists of two tranches, Tranche A and Tranche B, convertible into new fully paid ordinary shares of Alvotech.

Key Points: 
  • Reference is made to the announcement issued earlier today about the completion of a private placement of subordinated convertible bonds.
  • Alvotech intends to use the majority of the net proceeds from the private placement offering to replace a US$50 million unsecured subordinated loan from Alvogen (“Alvogen Facility”) which was announced on November 16, 2022 .
  • In accordance with the Alvogen Facility agreement, associated rights by Alvogen to procure warrants representing up to 4.0% of Alvotech’s ordinary share capital will no longer apply.
  • Certain statements in this communication may be considered “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, as amended.

Alvotech Completes $59.7 Million Private Placement

Retrieved on: 
Friday, December 16, 2022

REYKJAVIK, Iceland, Dec. 16, 2022 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced completion of a private placement of approximately US$59.7 million, at current exchange rates, of subordinated convertible bonds (the “Bonds”), convertible into new fully paid ordinary shares of Alvotech.

Key Points: 
  • REYKJAVIK, Iceland, Dec. 16, 2022 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced completion of a private placement of approximately US$59.7 million, at current exchange rates, of subordinated convertible bonds (the “Bonds”), convertible into new fully paid ordinary shares of Alvotech.
  • Alvotech intends to use the majority of the net proceeds from the private placement offering to replace a US$50 million unsecured subordinated loan from Alvogen (“Alvogen Facility”) which was announced on November 16, 2022 .
  • Alvotech will issue the Bonds in an aggregate principal amount of approximately US$59.7 million, at today’s exchange rate, in the form of subordinated convertible bonds, with a maturity of 36 months and in two tranches.
  • Alvotech is a biotech company, founded by Robert Wessman, focused solely on the development and manufacture of biosimilar medicines for patients worldwide.

Alvotech Completes $59.7 Million Private Placement

Retrieved on: 
Friday, December 16, 2022

REYKJAVIK, Iceland, Dec. 16, 2022 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced completion of a private placement of approximately US$59.7 million, at current exchange rates, of subordinated convertible bonds (the “Bonds”), convertible into new fully paid ordinary shares of Alvotech.

Key Points: 
  • REYKJAVIK, Iceland, Dec. 16, 2022 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced completion of a private placement of approximately US$59.7 million, at current exchange rates, of subordinated convertible bonds (the “Bonds”), convertible into new fully paid ordinary shares of Alvotech.
  • Alvotech intends to use the majority of the net proceeds from the private placement offering to replace a US$50 million unsecured subordinated loan from Alvogen (“Alvogen Facility”) which was announced on November 16, 2022 .
  • Alvotech will issue the Bonds in an aggregate principal amount of approximately US$59.7 million, at today’s exchange rate, in the form of subordinated convertible bonds, with a maturity of 36 months and in two tranches.
  • Alvotech is a biotech company, founded by Robert Wessman, focused solely on the development and manufacture of biosimilar medicines for patients worldwide.

Valour Inc. Announces Exclusive Partnership with Autostock, a Swedish Trading Platform to Launch Automated Trading Strategy Designed to Capture the Weekly Effects of the Bitcoin Price

Retrieved on: 
Thursday, December 1, 2022

Autostock AB is a Swedish analysis/trading platform exclusively connected to Nordnet Bank, offering advanced technical analysis methods, automated trading facilities and algorithmic strategies.

Key Points: 
  • Autostock AB is a Swedish analysis/trading platform exclusively connected to Nordnet Bank, offering advanced technical analysis methods, automated trading facilities and algorithmic strategies.
  • "Stepping into the digital assets space, with an automated strategy specifically designed to capture the weekly effects of Bitcoin is a first for Autostock," said Rikard Nilsson, CEO of Autostock.
  • "Partnering with Valour and using their Bitcoin ETP, without management fees, creates a unique opportunity and is the perfect choice for our clients."
  • Valour offers fully hedged digital asset ETPs with low to zero management fees, with product listings across European exchanges, banks and broker platforms.

Aroma360 Revolutionizes Scent Marketing with the New Interactive Scenting Kiosk

Retrieved on: 
Monday, November 21, 2022

MIAMI, Nov. 21, 2022 /PRNewswire/ -- Aroma360, the leader in scent marketing and scent branding, has pioneered a brand-new marketing solution for businesses via the Interactive Scenting Kiosk (ISK), a free-standing LCD display with embedded essential oil diffusers.

Key Points: 
  • Businesses can maximize customer impact and ROI using the power of scent with the innovative, free-standing scented kiosk and LCD display
    MIAMI, Nov. 21, 2022 /PRNewswire/ -- Aroma360 , the leader in scent marketing and scent branding, has pioneered a brand-new marketing solution for businesses via the Interactive Scenting Kiosk (ISK), a free-standing LCD display with embedded essential oil diffusers.
  • It combines the traditional elements of visual advertising, interactive e-commerce, and the incredibly powerful science of scent to influence customer purchasing behavior, time spent in-store, and increase brand loyalty.
  • "Diffusing a signature scent through the ISK can increase the intent to purchase by over 80 percent, making a scenting strategy a smart marketing tactic for businesses," says Nadira Persaud, Chief Marketing Officer, Aroma360.
  • For more information about the Interactive Scenting Kiosk (ISK) and Aroma360, visit Aroma360.com .

Web3 Game Platform Iskra Raises $40M, Partners with Gate.io for Token Generation Event

Retrieved on: 
Thursday, September 22, 2022

SINGAPORE, Sept. 22, 2022 (GLOBE NEWSWIRE) -- Iskra, a web3 community game platform that raised $40M from Korean tech giants Krust, Wemade, Netmarble, LINE Studio and others, plans to hold its first Token Generation Event (TGE) on global exchange Gate.io.

Key Points: 
  • SINGAPORE, Sept. 22, 2022 (GLOBE NEWSWIRE) -- Iskra, a web3 community game platform that raised $40M from Korean tech giants Krust, Wemade, Netmarble, LINE Studio and others, plans to hold its first Token Generation Event (TGE) on global exchange Gate.io.
  • Despite challenging market conditions, Iskra continues to move forward with its development milestones and launch major components of its platform.
  • ISKRA 's community-forward system aligns the interests of the community by rewarding its stakeholders based on their participation, while integrating sustainable tokenomic solutions for game developers that join its platform.
  • Additionally, Gate.io is listed in the Best Crypto Exchanges for 2021 with a rating of 4.5 by Forbes Advisor.

Iskra Announces New Games, Redefining Game Publishing at Korea Blockchain Week

Retrieved on: 
Friday, August 12, 2022

SEOUL, KOREA, Aug. 12, 2022 (GLOBE NEWSWIRE) -- Iskra took the stage at Korea Blockchain Week, outlining their vision of game publishing in the era of Web3.

Key Points: 
  • SEOUL, KOREA, Aug. 12, 2022 (GLOBE NEWSWIRE) -- Iskra took the stage at Korea Blockchain Week, outlining their vision of game publishing in the era of Web3.
  • Iskra plans on distributing up to 100% of all platform fees to every stakeholder, based on their participation.
  • The Iskra game partnership strategy revolves around game development experience and content-specific potential for web3.
  • HDLABS is building and expanding the blockchain system for game development and games by providing innovative blockchain service solutions with creative know-how and experience from various expertise.